Viewing Study NCT02504333


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-02-25 @ 9:45 PM
Study NCT ID: NCT02504333
Status: COMPLETED
Last Update Posted: 2023-10-03
First Post: 2015-07-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Study of Nab-paclitaxel and Gemcitabine Followed by AG-mFOLFOX in Patients With Metastatic Pancreatic Adenocarcinoma
Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module